New genetic evidence for involvement of the dopamine system in migraine with aura

Human Genetics

Volumn 125, Issue 3, 2009, Pages 265-279

  Todt, Unda ^a   Netzer, Christian ^a   Toliat, Mohammad ^a,b   Heinze, Axel ^c   Goebel, Ingrid ^a   Nürnberg, Peter ^a,b   Göbel, Hartmut ^c   Freudenberg, Jan ^d   Kubisch, Christian ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Kiel Pain and Headache Centre   (Germany)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; PROTEIN SLC6A3; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HAPLOTYPES; HUMANS; MALE; MIGRAINE WITH AURA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2;

EID: 63249107479     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-009-0623-z     Document Type: Article

References (53)

1. Akerman S, Goadsby PJ (2007) Dopamine and migraine: Biology and clinical implications. Cephalalgia 27:1308-1314
2. Arinami T, Gao M, Hamaguchi H, Toru M (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6:577-582
3. Asuni C, Cherchi A, Congiu D, Piccardi MP, Del Zompo M, Stochino ME (2007) Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 8:185-189
4. Cader ZM, Noble-Topham S, Dyment DA, Cherny SS, Brown JD, Rice GP, Ebers GC (2003) Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 12:2511-2517
5. Cardon LR, Abecasis GR (2003) Using haplotype blocks to map human complex trait loci. Trends Genet 19:135-140
6. Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009-1013
7. DSouza UM, Craig IW (2006) Functional polymorphisms in dopamine and serotonin pathway genes. Hum Mutat 27:1-13
8. de Sousa SC, Karwautz A, Wober C, Wagner G, Breen G, Zesch HE, Konrad A, Zormann A, Wanner C, Kienbacher C, Collier DA, Wober-Bingol C (2007) A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura. Ann Neurol 61:574-578
9. Del Zompo M (2000) Dopaminergic hypersensitivity in migraine: Clinical and genetic evidence. Funct Neurol 15(Suppl 3):163-170
10. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781-786
11. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55:997-1004
12. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T (1998) The D2 receptor NcoI allele: Absence of allelic association with migraine with aura. Neurology 51:928
13. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121
14. Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR (2006) Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 251:118-123
15. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152-156
16. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520
17. Guan Y, Stephens M (2008) Practical issues in imputation-based association mapping. PLoS Genet 4:e1000279
18. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn Cephalalgia 24 (Suppl 1): 9-160
19. International_HapMap_Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320
20. Karwautz A, Campos de Sousa S, Konrad A, Zesch HE, Wagner G, Zormann A, Wanner C, Breen G, Ray M, Kienbacher C, Natriashvili S, Collier DA, Wober C, Wober-Bingol C (2008) Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura. J Neural Transm 115:91-95
21. Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, Bertranpetit J, Bindoff LA, Comas D, Holmlund G, Kouvatsi A, Macek M, Mollet I, Parson W, Palo J, Ploski R, Sajantila A, Tagliabracci A, Gether U, Werge T, Rivadeneira F, Hofman A, Uitterlinden AG, Gieger C, Wichmann HE, Ruther A, Schreiber S, Becker C, Nurnberg P, Nelson MR, Krawczak M, Kayser M (2008) Correlation between genetic and geographic structure in Europe. Curr Biol 18:1241-1248
22. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3:35-40
23. Maude S, Curtin J, Breen G, Collier D, Russell G, Shaw D, Clair DS (2001) The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease. Psychiatr Genet 11:49-52
24. McCallum LK, Fernandez F, Quinlan S, Macartney DP, Lea RA, Griffiths LR (2007) Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility. Eur J Neurol 14:706-707
25. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP (2001) The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79:1033-1038
26. Mill J, Asherson P, Craig I, D'Souza UM (2005) Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet 6:3
27. Miller GM, Madras BK (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44-55
28. Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23:301-305
29. Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Hum Mol Genet 1:286
30. Netzer C, Todt U, Heinze A, Freudenberg J, Zumbroich V, Becker T, Goebel I, Ohlraun S, Goebel H, Kubisch C (2006) Haplotype-based systematic association studies of ATP1A2 in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 141B:257-260
31. Netzer C, Freudenberg J, Heinze A, Heinze-Kuhn K, Goebel I, McCarthy LC, Roses AD, Gobel H, Todt U, Kubisch C (2008a) Replication study of the insulin receptor gene in migraine with aura. Genomics 91:503-507
32. Netzer C, Freudenberg J, Toliat MR, Heinze A, Heinze-Kuhn K, Thiele H, Goebel I, Nurnberg P, Ptacek LJ, Gobel H, Todt U, Kubisch C (2008b) Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 147B:37-41
33. Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 116B:103-125
34. Palotie ABR, Wessman M (2002) Migraine. In: King RARJ, Motulsky AG (eds) The Genetic Basis of common diseases. Oxford University Prss, Oxford, pp 935-947
35. Payseur BA, Place M, Weber JL (2008) Linkage disequilibrium between STRPs and SNPs across the human genome. Am J Hum Genet 82:1039-1050
36. Peroutka SJ (1997) Dopamine and migraine. Neurology 49:650-656
37. Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201-206
38. Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14-21
39. Porter CJ, Nahmias J, Wolfe J, Craig IW (1992) Dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase (DBH) locus. Nucleic Acids Res 20:1429
40. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
41. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
42. Rebaudengo N, Rainero I, Parziale A, Rosina F, Pavanelli E, Rubino E, Mazza C, Ostacoli L, Furlan PM (2004) Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia 24:503-507
43. Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. Bmj 311:541-544
44. Schaid DJ (2004) Evaluating associations of haplotypes with traits. Genet Epidemiol 27:348-364
45. Shepherd AG, Lea RA, Hutchins C, Jordan KL, Brimage PJ, Griffiths LR (2002) Dopamine receptor genes and migraine with and without aura: An association study. Headache 42:346-351
46. Sicuteri F (1977) Dopamine, the second putative protagonist in headache. Headache 17:129-131
47. Stochino ME, Asuni C, Congiu D, Del Zompo M, Severino G (2003) Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes. Pharmacol Res 48:531-534
48. Tang Y, Buxbaum SG, Waldman I, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2006) A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 60:1034-1038
49. Todt U, Freudenberg J, Goebel I, Heinze A, Heinze-Kuhn K, Rietschel M, Gobel H, Kubisch C (2006) Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67:1707-1709
50. Wei J, Ramchand CN, Hemmings GP (1997) Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 99:52-55
51. Wellcome_Trust_Case_Control_Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678
52. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515-522
53. Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, Sun F (2004) Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 14:908-916